Clinical Trial Update: Paclitaxel + Carboplatin With/Out Cediranib Maleate in Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2, Phase 3]

View source ↗

Summary

A multicenter trial evaluated paclitaxel and carboplatin with or without cediranib in stage III or IV non-small cell lung cancer, with completed Phase 2/3 data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Cediranib (Cediranib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Lung Cancer | Phase 2, Phase 3 | Status: COMPLETED